The first quarter with Kloeckner inside made Worthington Steel far larger and loss-making on the bottom line. The real prize, operating control through a domination agreement, is still waiting on approvals.
Silicon Motion Technology (NasdaqGS: SIMO) has scheduled its third quarter 2026 results for late October. The company, which describes itself as the global leader in NAND flash controllers, cites trade and supply chain pressures among its risks.
Gix Internet Ltd. (Nasdaq: GIXI) now has robots carrying blood and bone marrow at Sheba Medical Center. GSN asks whether that expanded project can serve as a reference site for the U.S. healthcare organizations the company is now approaching.
Three conference posters lay out the biology behind lanifibranor, the French biotech's lead drug candidate. They explain the theory; they do not replace the Phase 3 trial results the company expects this quarter.
A short letter from Buenos Aires splits one technology division into two, with AI and engineering each reporting straight to the Executive Chairman. The structure is clear; what it is meant to deliver is not yet spelled out.
Comtech is selling most of its satellite and space business to an affiliate of Gilat Satellite Networks. Its new finance chief has satellite experience, which says something about how carefully the exit is being handled.
Three conference posters lay out the biology behind lanifibranor, the French biotech's lead drug candidate. They explain the theory; they do not replace the Phase 3 trial results the company expects this quarter.
Silicon Motion Technology (NasdaqGS: SIMO) has scheduled its third quarter 2026 results for late October. The company, which describes itself as the global leader in NAND flash controllers, cites trade and supply chain pressures among its risks.
RedHill Biopharma (Nasdaq: RDHL) used an $18 million payout from selling its stake in one drug to buy the commercial rights to two others. The Ledger traces the cash flow and asks what the strategic reset buys.
South African education group ADvTECH reported revenue of R5 060 million for the six months to 30 June 2026 and declared an interim dividend of 53.0 cents per share.
A short letter from Buenos Aires splits one technology division into two, with AI and engineering each reporting straight to the Executive Chairman. The structure is clear; what it is meant to deliver is not yet spelled out.
Rimfire Pacific Mining reports scandium recovery data that could point to lower capital processing at Murga, but the headline projection rests on extending 15 weeks of bottle roll results.
Safe Pro Group has given preliminary, unaudited third-quarter revenue far above last year, which it credits to U.S. defense subcontracts. The final close, and what comes after it, will show how much of that is repeatable.
Arrive AI Inc. (NASDAQ: ARAI) is launching a dedicated defense division to adapt its autonomous delivery infrastructure for military use. The company says the move could open non-dilutive government funding, but it has disclosed no contracts.
A California sales tax exclusion for a planned silicon wafer plant is real, but it is a discount on purchases not yet made, and the release says almost nothing about how those purchases will be paid for.
Astro Digital plans to go public by merging with Proem Acquisition Corp I (Nasdaq: PAAC). GSN asks whether its claims of growth and positive adjusted EBITDA can support a roughly $587 million valuation.
A Phase 3 trial of firmonertinib in an EGFR exon 20 lung cancer failed on its main independent measure while looking better on others. ArriVent now has to decide what that split result is worth.
A test-equipment maker is buying into a probe and interface specialist to speed AI-era chips to production. The deal opens several futures, and the announcement settles none of them.
CTO Realty Growth (NYSE: CTO) paid $103 million for a nearly full open-air power center near Kansas City, lifting its 2026 investment total to $439 million. GSN asks how long that pace can last and how the deal was paid for.
Nova Minerals (NYSE American: NVA) has received the final equipment for its planned Alaska antimony refinery, a project supported by a $43.4 million U.S. Department of War award. The Ledger examines what stands between delivered equipment and first antimony: permits, construction and feed.
Gix Internet Ltd. (Nasdaq: GIXI) now has robots carrying blood and bone marrow at Sheba Medical Center. GSN asks whether that expanded project can serve as a reference site for the U.S. healthcare organizations the company is now approaching.
Strategic Metals has completed a property option deal that leaves it with a significant minority stake and retained royalties in Trifecta Gold's Yukon projects.
London-based OKYO Pharma has enrolled the first patients in a Phase 3 trial for a painful eye condition with no FDA-approved treatment. The start is real. The answer is still a trial away.
American Pacific Mining (OTCQX: USGDF) is imaging hole M26C-02 at its Madison project in Montana before drilling again. The reported grades are high, but whether the zone continues beyond existing intersections is still unproven.
Prospector Metals has finished its 2026 drilling program at the Yukon ML Project with high-grade gold intercepts. The release does not say how the 2027 program will be paid for, and that is the next question.
By closing its purchase of Israeli retail media firm Hedia, A2Z Cust2Mate has bought advertiser relationships and campaign execution capabilities. The open question is whether an acquired sales team can sell A2Z's own in-store media inventory.
Comtech is selling most of its satellite and space business to an affiliate of Gilat Satellite Networks. Its new finance chief has satellite experience, which says something about how carefully the exit is being handled.
Arrive AI Inc. (NASDAQ: ARAI) is launching a dedicated defense division to adapt its autonomous delivery infrastructure for military use. The company says the move could open non-dilutive government funding, but it has disclosed no contracts.
Gix Internet Ltd. (Nasdaq: GIXI) now has robots carrying blood and bone marrow at Sheba Medical Center. GSN asks whether that expanded project can serve as a reference site for the U.S. healthcare organizations the company is now approaching.
Strategic Metals has completed a property option deal that leaves it with a significant minority stake and retained royalties in Trifecta Gold's Yukon projects.
A test-equipment maker is buying into a probe and interface specialist to speed AI-era chips to production. The deal opens several futures, and the announcement settles none of them.
Silicon Motion Technology (NasdaqGS: SIMO) has scheduled its third quarter 2026 results for late October. The company, which describes itself as the global leader in NAND flash controllers, cites trade and supply chain pressures among its risks.
A Phase 3 trial of firmonertinib in an EGFR exon 20 lung cancer failed on its main independent measure while looking better on others. ArriVent now has to decide what that split result is worth.
Editas Medicine has cleared the hurdle to start dosing people with EDIT-401, a one-time gene edit meant to lower LDL cholesterol. The primate data are striking; the human question is entirely open.
Safe Pro Group has given preliminary, unaudited third-quarter revenue far above last year, which it credits to U.S. defense subcontracts. The final close, and what comes after it, will show how much of that is repeatable.
A Denver-based AI investor points to 124 unmanned French fuel stations as proof for its portfolio company Manako Labs. The release does not say that any of that French money reaches TaoWeave.
Rank One Computing has added biometrics scientist Dr. Anil Jain to its board, alongside an existing advisory role. GSN asks whether deep scientific expertise on the board can turn into commercial traction for its Vision AI platform.
Wolfspeed (NYSE: WOLF) has received a conditional commitment for up to $1.5 billion in financing from the U.S. Department of War. This report examines whether the capital would stabilize the silicon carbide maker or bind it to a rigid national security agenda.
A short letter from Buenos Aires splits one technology division into two, with AI and engineering each reporting straight to the Executive Chairman. The structure is clear; what it is meant to deliver is not yet spelled out.
Rimfire Pacific Mining reports scandium recovery data that could point to lower capital processing at Murga, but the headline projection rests on extending 15 weeks of bottle roll results.
Nova Minerals (NYSE American: NVA) has received the final equipment for its planned Alaska antimony refinery, a project supported by a $43.4 million U.S. Department of War award. The Ledger examines what stands between delivered equipment and first antimony: permits, construction and feed.
The first quarter with Kloeckner inside made Worthington Steel far larger and loss-making on the bottom line. The real prize, operating control through a domination agreement, is still waiting on approvals.
Three conference posters lay out the biology behind lanifibranor, the French biotech's lead drug candidate. They explain the theory; they do not replace the Phase 3 trial results the company expects this quarter.
London-based OKYO Pharma has enrolled the first patients in a Phase 3 trial for a painful eye condition with no FDA-approved treatment. The start is real. The answer is still a trial away.
American Pacific Mining (OTCQX: USGDF) is imaging hole M26C-02 at its Madison project in Montana before drilling again. The reported grades are high, but whether the zone continues beyond existing intersections is still unproven.
Prospector Metals has finished its 2026 drilling program at the Yukon ML Project with high-grade gold intercepts. The release does not say how the 2027 program will be paid for, and that is the next question.
By closing its purchase of Israeli retail media firm Hedia, A2Z Cust2Mate has bought advertiser relationships and campaign execution capabilities. The open question is whether an acquired sales team can sell A2Z's own in-store media inventory.
Blaize revised its full-year revenue range to far above its latest quarter, resting it on signed orders, inventory, suppliers and timely payment, days after announcing cuts to about a quarter of its staff.
CTO Realty Growth (NYSE: CTO) paid $103 million for a nearly full open-air power center near Kansas City, lifting its 2026 investment total to $439 million. GSN asks how long that pace can last and how the deal was paid for.
QCi's new investor deck leads with a debt-free cash pile. The open question is how much business that money is buying, and how soon customers start paying their share.